Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION - Hoth Therapeutics, Inc. | f10k2020ex32-1_hoththera.htm |
| EX-31.2 - CERTIFICATION - Hoth Therapeutics, Inc. | f10k2020ex31-2_hoththera.htm |
| EX-31.1 - CERTIFICATION - Hoth Therapeutics, Inc. | f10k2020ex31-1_hoththera.htm |
| EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - Hoth Therapeutics, Inc. | f10k2020ex21-1_hoththera.htm |
| EX-4.5 - DESCRIPTION OF THE REGISTRANT'S SECURITIES - Hoth Therapeutics, Inc. | f10k2020ex4-5_hoththerap.htm |
| 10-K - ANNUAL REPORT - Hoth Therapeutics, Inc. | f10k2020_hoththerapeuticsinc.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Form S--1 No. 333-233563, Form S-3 No. 333-236887 and Form S-3 No. 333-251994 of Hoth Therapeutics, Inc. of our report dated March 16, 2021, relating to the consolidated financial statements, which appear in this Form 10-K.
/s/ WithumSmith+Brown, PC
New York, New York
March 16, 2021